Order Revanesse® Kiss™ w/ Lidocaine for Clinics

Revanesse® Kiss™ w/ Lidocaine is a hyaluronic acid dermal filler for professional lip procedures in licensed clinics, med spas, and aesthetic practices. Each pack contains two sterile prefilled syringes, with 1.2 mL of clear gel per syringe, formulated with 25 mg/mL hyaluronic acid and 0.3% lidocaine. Clinics can order Revanesse Kiss with Lidocaine to support lip contouring workflows that require controlled placement, sterile handling, and documented lot rotation.

This product is intended for trained healthcare professionals using established injection protocols. The integrated lidocaine helps reduce injection discomfort during treatment, while the cohesive HA gel supports lip volume, border definition, and symmetry refinement when clinically appropriate.

Clinic Ordering, Pack Size, and Price Context

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account.

The pack format supports practical treatment-room planning: two sterile prefilled syringes, each containing 1.2 mL. This differs from search wording that may describe Revanesse Kiss 1ml, Revanesse Kiss 1x1ml, or Revanesse Kiss syringe 1ml; clinics should rely on the product packaging shown during ordering and the labeling received with the shipment. The SKU for this item is 89753.

Use clinic ordering records to document quantity received, lot number, expiration date, and assigned storage area. For practices building a broader lip service inventory, the Revanesse collection can be reviewed through the Revanesse brand assortment.

Professional Applications for Lip Procedures

Revanesse Kiss Lip Filler is used in aesthetic practice for lip augmentation, lip contour definition, and proportional refinement of the upper and lower lips. Providers may incorporate it into protocols for the vermillion border, cupid’s bow shaping, central lip volume, or symmetry work after clinical assessment.

The gel supplements soft tissue with crosslinked hyaluronic acid, a water-binding molecule used in dermal filler products to add structure and hydration within treated tissue. In the lips, the practical goal is controlled shaping rather than generalized facial volumization. This makes product selection, injection depth, patient selection, and follow-up documentation important parts of clinic workflow.

Clinical teams often pair lip filler appointments with standardized photography, consent documentation, and injector notes. For broader technique and brand context, see Revanesse filler use across facial features and lip filler treatment considerations.

Composition and Handling Characteristics

Revanesse Kiss HA filler contains crosslinked hyaluronic acid at 25 mg/mL with lidocaine hydrochloride at 0.3%. The gel is clear and colorless, supplied sterile, and packaged in ready-to-use syringes for professional administration.

The prefilled syringe format can reduce setup time compared with products requiring additional transfer steps. Staff should keep syringes in original packaging until preparation and should verify the lot and expiration before use. Follow the manufacturer’s instructions for use, aseptic technique, and any clinic-specific protocols for dermal filler handling.

Key Features for Treatment-Room Workflow

• Hyaluronic acid base designed for lip contouring and soft tissue definition.
• Integrated lidocaine to support comfort during injection sessions.
• Prefilled syringe format for efficient chairside preparation.
• Two 1.2 mL syringes per pack for practical inventory planning.
• Sterile blister packaging to protect the syringe until use.
• Clear labeling with lot and expiration information.
• Cohesive gel behavior suited to controlled lip shaping.
• Professional-use format for licensed aesthetic practices.

Because lip work often requires small, deliberate placement decisions, injector familiarity with gel behavior matters. Teams may document extrusion feel, molding response, and post-procedure outcomes to keep product selection consistent across providers.

Benefits in Aesthetic Practice

Revanesse Kiss injectable gel can fit clinics that want a dedicated lip HA filler with lidocaine already included. The formulation supports precise placement for volume enhancement, lip border definition, and subtle balancing when the patient is an appropriate candidate and the injector follows professional technique.

The integrated anesthetic may reduce the need for additional chairside comfort steps in many routine workflows, although clinics may still use their own comfort protocols when appropriate. Hyaluronic acid gels can often be shaped after placement, allowing injectors to refine contour during the appointment.

Appointment planning should include consultation, contraindication screening, informed consent, baseline images, post-care instructions, and a follow-up pathway. For patient-experience planning around duration and aftercare expectations, consult lip filler duration and care considerations.

Safety, Contraindications, and Monitoring

Dermal fillers should be administered only by trained medical professionals who understand facial anatomy, vascular risk, injection technique, and emergency response protocols. Common transient reactions for HA lip fillers may include swelling, bruising, redness, tenderness, itching, firmness, or temporary asymmetry at the injection site.

Clinics should screen candidates for relevant contraindications and risk factors before treatment. Important considerations may include active infection or inflammation at the intended injection site, known hypersensitivity to product components, history of severe allergy or anaphylaxis, bleeding tendency, use of anticoagulant or antiplatelet medications, immune status, pregnancy or breastfeeding considerations, and prior filler history in the treatment area.

Rare but serious complications can occur with dermal filler injection, including vascular occlusion, tissue compromise, infection, nodules, inflammatory reactions, and visual symptoms if product enters or compresses a blood vessel. Providers should counsel patients on warning signs, maintain appropriate protocols, and arrange urgent evaluation when symptoms suggest vascular or infectious complications.

Lidocaine-containing fillers require attention to lidocaine sensitivity and cumulative exposure when multiple anesthetic products are used during the same visit. For more detail on the role of anesthetic in filler procedures, see lidocaine in dermal filler workflows.

Storage, Documentation, and Logistics

Store and handle Revanesse® Kiss™ w/ Lidocaine according to the manufacturer’s labeling and your clinic’s medical inventory procedures. Keep product in its original sterile packaging until treatment-room preparation, and avoid using any syringe if the blister, cap, label, or syringe appears compromised.

Inventory teams should record lot number, expiration date, quantity received, and use date. This supports traceability, expiration rotation, adverse event documentation, and multi-location purchasing controls. Temperature-controlled handling when required and tracked US delivery can help clinics coordinate supply with scheduled injection blocks.

Quick tip: Assign dermal fillers to a dedicated inventory log so staff can reconcile syringes before and after clinic sessions.

How Long Results May Last

Duration varies by patient anatomy, injection technique, treatment volume, product placement, metabolism, and follow-up care. Lip fillers generally require periodic reassessment because lip tissue is mobile and highly vascular compared with some other facial areas.

Clinics should avoid promising a fixed duration for every patient. Instead, document baseline appearance, treatment plan, amount used, and follow-up observations. This helps providers decide whether future maintenance, touch-up, or a different rheology profile is more appropriate.

Comparable Revanesse Options

Clinics evaluating Revanesse Kiss for lips may also consider adjacent Revanesse fillers when a procedure calls for different tissue support. Product choice should reflect treatment area, desired projection, injector preference, gel characteristics, and the clinic’s established protocols.

• Revanesse Ultra with Lidocaine may be considered when practices want another lidocaine-containing Revanesse HA filler.
• Revanesse Contour with Lidocaine may fit broader contouring workflows that require more structural support.
• Revanesse Shape with Lidocaine can be reviewed for clinics building a wider Revanesse assortment.

Many providers also evaluate how Revanesse compares with other established HA filler brands. For a practical brand-level discussion, see Revanesse and Juvéderm comparison considerations.

Availability and Substitution Planning

When planning treatment blocks, align quantities with expected bookings, injector availability, and expiration rotation rather than relying on last-minute purchasing.

If your team uses substitutes during formulary planning, confirm that the alternative matches the clinical goal. Review syringe volume, lidocaine inclusion, gel behavior, intended treatment area, and injector familiarity before changing products within a lip protocol. Substitution decisions should be documented so patient records accurately reflect the product used.

Authoritative Sources

• Manufacturer information for Revanesse products

This content is for informational purposes only and is not a substitute for professional medical advice.